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A B S T R A C T
Purpose
To evaluate the signs and symptoms of dry eye and dinucleotide secretion in tears of keratoconus patients (KC) and
the potential effect of rigid gas permeable (RGP) contact lens wear.
Methods
Twenty-three KC patients and forty control subjects were enrolled in this study. Signs of dry eye including tear vol-
ume, tear stability and corneal staining along with symptoms were assessed using the McMonnies questionnaire. Tears
were collected using Schirmer strips, and dinucleotide concentrations in collected tears measured using high pressure liq-
uid chromatography. Values obtained in KC and controls were compared. The effect of contact lens wear in KC was also
assessed.
Results
KC eyes showed a significantly lower tear volume compared to controls, shorter tear break up time (TBUT), higher
corneal staining and higher McMonnies dry eye questionnaire scores (p < 0.05). When compared with non-wearers, KC
contact lens wearers showed significantly higher symptoms, lower Schirmer and TBUT values (p < 0.05). Concentration
of Ap4A (0.695 ± 0.304 μM vs. 0.185 ± 0.178 μM) and Ap5A (0.132 ± 0.128 μM vs. 0.045 ± 0.036 μM) were higher in
KC compared to controls (p < 0.001) and only Ap4A was statistically higher in RGP wearers compared to non-wearers
(0.794 ± 0.478 μM vs. 0.417 ± 0.313 μM) (p < 0.05).
Conclusion
Signs and symptoms of dry eye as well as concentrations of Ap4A and Ap5A were markedly increased in KC patients
compared to controls. Moreover, Ap4A and symptoms of dry eye were statistically higher in RGP wearers compared to
non-wearers. This seems to indicate that factors such as RGP contact lens wear might exacerbate the clinical condition of
dry eye.
© 2016 Published by Elsevier Ltd.
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1. Introduction
Keratoconus (KC) is an ocular pathology causing a protrusion of
the cornea. This pathology is bilateral, asymmetric and progressive
[1,2] and affects about 2% of the population worldwide [2]. The cause
of KC is not well understood, but it seems to be multifactorial. Fac-
tors such as an exposure to ultraviolet light, allergy and genetic mech-
anisms are the predominant reasons triggering the disease [3–5]. Other
factors described in the literature as risk factors for the progression of
KC include eye rubbing, with half of the patients reporting intense eye
rubbing [6]. The need these patients feel to rub their eyes is due to oc-
ular discomfort symptoms including itching, which might be closely
related to eye dryness [7].
Only a very small number of studies have investigated the link be-
tween KC and dry eye [8–10]. In these studies, the results show a
lower tear break time (BUT) in KC patients and a marked presence of
corneal staining. In addition, patients with KC have a higher concen
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tration of pro-inflammatory molecules such as interleukins and metal-
loproteinases compared to healthy subjects, this being even more el-
evated in patients using RGP contact lenses [11–13]. Inflammation is
one of the most important signs described in the definition of dry eye
given by the DEWS 2007 [14]. All these findings suggest a possible
interaction between KC and dry eye.
In recent years, the presence of diadenosine polyphosphates in hu-
man tears and in aqueous humor has been shown [15,16]. These mol-
ecules can increase tear secretion when instilled topically [17]. More-
over, these substances can increase the production of lysozyme in
tears, contributing to ocular surface defense [18]. Additionally, some
of these molecules accelerate the rate of corneal wound healing (di-
adenosine tetraphosphate, Ap4A) while others inhibit this process (di-
adenosine pentaphosphate, Ap5A) [19]. These molecules have been
proposed as objective biomarkers of dry eye, since their presence is
significantly increased in patients with this disease [20,21]. In a recent
study, it has been found that Ap4A tear concentrations were higher
in KC patients than healthy subjects. All patients with KC were RGP
wearers [10]. A higher Ap4A concentration in healthy RGP wearers
has also been shown to be related [22].
The release of diadenosine polyphosphates to the tears is caused
by shear stress. Corneal epithelial cells release these molecules as a
http://dx.doi.org/10.1016/j.clae.2016.04.009










2 Contact Lens and Anterior Eye xxx (2016) xxx-xxx
consequence of the lid contact during the blinking process [23]. The
CLEK study found an increase of about 25% of corneal scarring in KC
patients wearing RGP contact lenses compared to non-users, possibly
partly due to the abrasion caused by the contact lens to the corneal sur-
face [24]. We hypothesized that patients with KC who wear RGP con-
tact lenses have higher tear concentrations of diadenosine polyphos-
phates.
To the best of our knowledge, there is currently no study that eval-
uates the influence of RGP lenses on tears and ocular surface physi-
ology in patients suffering from KC. Therefore, the aim of this study
is to examine the signs, symptoms and adenosine polyphosphate tear
concentrations in patients with and without KC as well as the influ-
ence of RGP contact lens wear on these parameters in KC.
2. Methods
2.1. Patients
Twenty-three patients (13 males and 10 females) with ages ranging
from 20 to 59 (average 34.75 ± 6.12 years) with KC and forty healthy
subjects (24 males and 16 females) with ages ranging from 20 to 61
(29.02 ± 6.92 years) were recruited at the Clinical & Experimental
Optometry Research Lab (University of Minho, Braga, Portugal) and
at the Optometric Clinic of the Faculty of Optic and Optometry (Uni-
versity of Complutense, Madrid, Spain). All patients with KC were
diagnosed by an external ophthalmologist and recommended to the
research. The study was conducted in compliance with good clinical
practice guidelines, institutional review board regulations, informed
consent regulations, and the tenets of the Declaration of Helsinki
(WMA, 2008) [25]. The protocol of the study was approved by the
institutional review board of the University Complutense of Madrid.
All the subjects enrolled in the study were adults over 18 years of
age, who were able to give informed consent. After the purpose of the
study was explained and all doubts clarified to the participants, a con-
sent form was presented and signed by both the patient and the re-
searcher.
KC patients should have been wearing spectacles or aspheric RGP
corneal design at least during the last year to be part of the study. Pa-
tients with soft contact lenses, hybrid or scleral or previous surgery
were excluded. In order to study the influence of RGP lens wearing
on the ocular surface integrity, the KC group was divided into users
and non-users of RGP lenses. Control group subjects had all worn soft
contact lenses on a monthly wear daily basis during the previous 2
years, except eight subjects who had never worn contact lenses at all.
Additional demographic characteristics of the population are shown in
Table 1.
Table 1





Patients 40 23 11 12
Mean age
(years) ± SD
29.02 ± 6.92 34.75 ± 6.12 35.96 ± 4.82 33.11 ± 3.16
Age range (years) [20,61] [18,59] [23,59] [18,44]
Gender (male/
female)
[24,16] [13,10] [7,4] [6,6]
Mean keratometry (D)
Flat 43.87 ± 2.53 49.46 ± 6.32 46.97 ± 3.35 51.97 ± 5.62
Steep 45.31 ± 1.39 56.35 ± 8.76 53.25 ± 6.53 60.81 ± 6.79
2.2. Trials
Tests of tear volume, tear stability, corneal staining and recording
of subjective symptoms including dryness and discomfort using the
McMonnies questionnaire were carried out at the beginning of the day
before contact lens wear [26,27].
Tear secretion was measured using the Schirmer I test (without
anaesthesia). The tear collection was always performed following the
Van Bijsterveld criteria [28]. The Schirmer strip (Tear Flo, HUB phar-
maceuticals, USA) was placed on the temporal tarsal conjunctiva of
the lower lid for 5 min with the eyes closed. The volume of tears, as
millimetres of moistened strip, were recorded and the Schirmer strips
were placed in Eppendorf tubes containing 500 μL of Ultrapure water,
then the samples were frozen at −80 °C until the high pressure liquid
chromatography (HPLC) analysis was performed [20].
To avoid contaminating the strip with fluorescein, fluorescein was
applied five minutes after the Schirmer I test to evaluate tear break
up time (TBUT) and corneal staining. In order to warrant repeatability
of the staining procedure, a solution was prepared using a 10% con-
centration of sodium fluorescein diluted in saline (NaCl 0.9%). For
each application, a micropipette with 5 μl of diluted fluorescein solu-
tion was applied in the inferior conjunctival sac and 20 s later TBUT
was analyzed through a slit lamp at 16x, using a chronograph to record
the time to break after the patient was asked to blink twice and then
keep their eyes open. The cornea was divided into five areas to record
the grade of staining and, as proposed by the Report of the National
Eye Institute and Industry-Sponsored Dry Eye Workshop [29], Cornea
and Contact Lens Research Unit (CCLRU) grading scales were used
[30].
2.3. Tear preparation and HPLC analysis
After thawing, the samples were strongly vortexed for 5 min. The
strips were carefully rinsed and the liquid in the Eppendorf tube was
heated in a 100 °C bath for 20 min to precipitate proteins. In order to
pellet the proteins, the tubes were centrifuged at 4000 rpm for 30 min.
Diadenosine polyphosphates are not degraded by this treatment as
previously demonstrated [31]. Supernatants were chromatographed
through SEP-PAK Accell QMA cartridges [32]. Briefly, 250 μL of
the supernatant was passed through the cartridges that were previously
mixed with 3 mL of ultrapure water. The elution of the nucleotides
and dinucleotides was performed by applying 1 mL of a solution con-
taining 0.2 M KCl, 0.1 M HCl. Prior to injection into the HPLC, sam-
ples were neutralised with KOH. These eluents were injected at a vol-
ume of 10–100 μL.
Determination and quantification of diadenosine polyphosphates
were performed by HPLC. The chromatographic system consisted of
a Waters 1515 isocratic HPLC pump, a 2487 dual absorbance detec-
tor and a Reodyne injector, all managed by the Breeze software from
Waters. The column was a Novapack C18 (15 cm length, 0.4 cm di-
ameter) from Waters. The system was equilibrated overnight with the
following mobile phase: 0.1 M KH2PO4, 2 mM tetrabutyl ammonium,
17% acetonitrile, pH 7.5 [19]. Detection was monitored at 260 nm
wavelength. All the peaks identified as putative dinucleotides were
taken for phosphodiesterase treatment. Phosphodiesterase from Cro-
talus adamanteus, from Sigma (St. Louis, Mo., USA; EC 3.1.4.1.)
at a concentration of 1.0 U/mL was incubated at room temperature
for 30 min with the corresponding putative dinucleotide. The digested
products were analysed by HPLC. Peaks were transformed into con-
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2.4. Statistical analysis
Data were analysed by statistical package SPSS version 15.0 for
Windows (SPSS, Inc., Chicago, IL). The values analyzed are the
means ± SD of the experiments performed. For statistical analysis,
one eye per subject was selected randomly. Normality of samples was
analyzed using the Shapiro-Wilk test. Sample size calculations were
performed with statistical software (Granmo 6.0; Institut Municipal
d’Investigacio ́n Medica, Barcelona, Spain). With an accepted two-
sided statistical significance threshold of 0.05 and a risk of 0.20, for
a standard deviation of 0.16 units for the diadenosine tetraphosphate
concentration and in order to detect a difference of 0.2 units or more,
13 subjects were needed to find statistically significant differences.
Parametric tests were used to compare the studied groups. Differences
between the control group and the KC group were estimated by the
Student-t test for independent samples. Due to small sample sizes of
KC subgroups, the Mann-Whitney U test was used to compare values
between them. p < 0.05 was considered statistically significant.
3. Results
Of all the KC subjects enrolled in the study, 16 patients were of
grade III, 5 patients of grade IV and 2 patients of grade V, according
to the KC severity score grading scale (9 grade III, 1 grade IV and 1
grade V were included in non RGP wearers and 7 grade III, 4 grade IV
and 1 grade V were included in RGP wearers) [33]. However, no data
were recorded about when the patients were diagnosed of KC. Consid-
ering that no correlation between grades and any test performed was
found, all the eyes were pooled together for further analysis. More-
over, no differences were found between soft contact lens wearers and
non-lens wearers in the control group and therefore the control groups
were not divided for additional analysis.
Results of the Schirmer test, TBUT, corneal staining, McMonnies
score and concentrations of Ap4A and Ap5A are summarized in Table
2. When comparing the control group and the KC group, the Schirmer
test indicated that the control group showed higher tear volume than
the KC group (p = 0.03). TBUT was statistically shorter in the KC
group than the control group (p < 0.001). Corneal staining scores were
3 fold higher in the KC patients than in healthy subjects (p < 0.001).
Also, the McMonnies questionnaire showed that the KC subjects had
statistically significant higher symptoms scores than the control group
(p < 0.001). Among the symptoms more frequently reported by KC
patients were: dryness (59%) and scratchiness (36%). Also, they more
frequently reported to have uncomfortable eyes in smoke and/or air-
conditioning conditions. Regarding Ap4A and Ap5A concentration,
KC patients showed higher concentration than control group, this be-
ing statistically significant in both dinucleotides (p < 0.001).
Table 2
Comparison between control group and keratoconus group. *p value < 0.05. Student-t
test for independent samples. For details see Section 2.
Test Control Keratoconus P value
Ap4A (μM) mean (SD) 0.185 ± 0.178 0.695 ± 0.304 <0.001*
Ap5A (μM) mean (SD) 0.045 ± 0.036 0.132 ± 0.128 <0.001*
Schirmer (mm) mean (SD) 19.87 ± 5.71 16.75 ± 7.65 0.031*
TBUT (s.) mean (SD) 12.13 ± 1.85 6.56 ± 2.88 <0.001*
Corneal staining mean (SD) 0.82 ± 0.51 2.81 ± 0.76 <0.001*
McMonnies score mean(SD) 7.01 ± 3.15 10.87 ± 3.68 <0.001*
When the KC group was divided into RGP wearers and non-RGP
wearers, statistical differences were found in the Schirmer test, TBUT,
the McMonnies test and Ap4A concentration (p < 0.05), but not in
corneal staining scores and Ap5A concentration (p > 0.05, Table 3).
RGP wearers showed less tear volume than the KC non-RGP
wearers. Moreover, the tear stability was shorter and symptoms were
higher in RGP wearers than spectacle wearers. Ap4A concentration
was higher in RGP wearers compared with non-wearers. Fig. 1 sum-
marizes the main outcomes of this study.
Table 3
Comparison between wearers and non-wearers of GP lenses in keratoconus group. *p
value < 0.05. Mann-Whitney U test. For details see Section 2.
Test No RGP RGP wearers P value
Ap4A (μM) mean (SD) 0.417 ± 0.313 0.794 ± 0.478 0.041*
Ap5A (μM) mean (SD) 0.093 ± 0.086 0.217 ± 0.176 0.064
Schirmer (mm) mean (SD) 20.05 ± 7.45 13.45 ± 5.89 0.044*
TBUT (s.) mean (SD) 8.11 ± 1.85 5.83 ± 1.23 0.002*
Corneal staining mean (SD) 2.42 ± 0.46 2.59 ± 0.29 0.287
McMonnies score mean(SD) 7.93 ± 3.56 12.45 ± 3.32 0.005*
Fig. 1. Diadenosine polyphosphate detection in tears of KC patients. Chromatographic
analysis of samples from KC patients showing the presence of two peaks identified as
Ap4A and Ap5A when compared to a commercial standard (upper record). A control
record (representing a healthy individual) can be compared with representative traces
of KC patients grouped, according to methods, in RGP wearers and non-RGP wear-
ers. Note that standards scale bar is different from the one for the samples. AUFS, Ab-
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4. Discussion
Currently, few scientific articles relate KC with dry eye syndrome
[8]. Recent studies of the tears of KC patients have focused on the
presence of pro-inflammatory molecules and their role on ectasia pro-
gression [11,34–36]. As we previously mentioned, the Dry Eye Work-
shop, published in 2007, includes the inflammation of ocular surface
as one of the possible signs of dry eye syndrome [29]. This led us to
consider that there could be a close relationship between dry eye syn-
drome and KC. This study evaluated and compared the signs of Ap4A
and Ap5A concentrations and another signs and symptoms of dry eye
in patients with KC and the influence of wearing GP contact lenses.
Previous studies examining dry eye signs and symptoms in KC pa-
tients who wore RGP lenses, had shown that the KC patients had in-
creased concentrations of Ap4A in their tears [10,37]. Current results
match better with the most recent study published [37] than the older
manuscript [10]. This is due to the low tear volume found in the KC
patient of the study published in 2014, being almost 4 times lower than
the other two studies (matched with Ap4A ratio between studies).
With the aim to evaluate if KC disease causes changes in din-
ucleotide concentration, the KC group was divided into RGP wear-
ers and RGP non-wearers. And the findings are very significant, be-
cause non-RGP wearing KC patients showed 2 times higher Ap4A
concentration than healthy subjects without contact lenses
(0.417 ± 0.313 μM vs. 0.185 ± 0.178 μM) [20]. Therefore, KC may
cause an increase in the concentration of Ap4A. Also, this study cor-
roborates the effect of RGP on the concentration of Ap4A found in a
previous study [22]. KC patients who wore RGP lenses had a 2 times
higher Ap4A concentration than Kc patients who did not wear RGP
lenses (0.794 ± 0.478 μM vs. 0.417 ± 0.313 μM).
The increase in Ap4A in patients of KC may be due to a mechan-
ical stimulation of the epithelial cells. It has been shown in both in
vitro and in vivo studies, that the release of the nucleotides is driven
by the shear stress produced on the corneal epithelial cells [23]. There
are many studies that report a high prevalence of eye rubbing in pa-
tients with KC, with percentages between 46% and 80% of eye rub-
bing [3,6]. It is therefore likely that friction between lids and cornea
is a mechanical stimulus for the release of dinucleotides to the tear.
Furthermore, contact lenses exert mechanical pressure on the corneal
epithelium in each blink, which may also stimulate the release of din-
ucleotides. In some studies, in which tear samples were taken before
and after contact lens wear, significantly increased concentrations of
Ap4A and Ap5A were found [22,38].
Nevertheless, KC patients who are not contact lens wearers also
showed statistically higher concentrations of dinucleotides than the
patients in the control group. The reasons for this observation are not
clear, but we have several hypotheses. It might be possible that the
increased curvature of the anterior surface of the cornea caused in-
creased friction in each blink on the corneal surface which stimulates
the release of the dinucleotides. No studies on the blinking frequency
in KC patients has been performed but lower density of epithelial
cells, primarily in the apical area have been reported, possibly due to
the blinking stress [39,40]. Another possibility is the presence of dry
eye associated with KC. There are some references in the literature
that relate KC with dry eye but they describe the presence of cytokines
such as interleukin-6 or Tumor necrosis factor (TNF-α) and metallo-
protease 9 (MMP-9) in the tears of patients with KC [12,41]. These
mediators are very important in the pathogenesis of dry eye [42,43].
In another study published in 2003, the authors reported a decrease in
tear volume and TBUT in patients with KC [8].
Besides the concentration of dinucleotides, other signs and symp-
toms of dry eye in patients with KC were evaluated. When compared
with the control group, we have found that patients with KC have less
tear volume, reduced tear stability, and more corneal staining, all of
which are statistically significant. These findings strongly suggest that
the increased concentrations of dinucleotides in KC are mainly caused
by the associated dry eye.
Regarding the tear volume and stability, KC patients who use con-
tact lenses had significantly lower values than those who are non-
users. A possible reason could be that GP contact lenses disrupt nor-
mal tear physiology by thinning and breakup of the tear film lipid
layer favoring the consequent increase in tear film evaporation [44].
Patients using contact lenses show a significant increase in the Mc-
Monnies test. These scores are considered marginal dry eye [45]. It
seems possible that the use of rigid gas permeable contact lenses is re-
lated to dry eye symptoms in these KC patients, though it would be
interesting to know how long each subjects had the disease as this may
be an influential factor.
Dogru et al. [8] also indicated that 81.5% of their patients reported
discomfort, irritation and foreign body sensation, although that study
does not differentiate between contact lens wearers and non-wearers.
Although, our KC patients are older, the percentage of patients diag-
nosed or treated of dry eye in the age range between 25 to 29 years old
and 30–34 years old was similar [46] and moreover, signs and symp-
toms of dry eye worsen with age, but it is accepted that the age of onset
is 45–50 years old, which could be potentially linked to hormonal fac-
tors [47]. However, KC patients did not show a relationship between
age and the parameters evaluated, which could be related to the narrow
age range and low subject numbers in our study. A future study with a
larger population may be necessary to evaluate the symptomatology of
dry eye in KC patients as a function of age including ages up to 60–70
years old. Otherwise, the same number of patients was recruited from
both places for both groups, control and KC group. We found no dif-
ferences between places for any parameter evaluated, but the KC sub-
groups division in function of the centre gives us very small samples
to make any conclusion. Therefore, more studies about environmental
conditions and dry eye signs and symptoms in KC patients should be
performed.
On the one hand, our patients using RGP lenses have no more
staining than non-wearers. This would indicate that symptoms in these
patients are not due to corneal damage but due to the contact lens
wear. In the case of contact lens wearers, several types of contact
lenses are currently fitted in KC patients, from soft contact lenses or
GP corneal contact lenses to gas permeable scleral contact lenses or
hybrid contact lenses [48,49]. On the other hand some studies have
found that gas permeable contact lens wear increases the presence of
pro-inflammatory molecules in tears of patients with KC [13]. Fur-
thermore, several studies have demonstrated that soft contact lens
wear provokes symptoms of dryness, especially at the end of the day
[50], but no studies with scleral or hybrid contact lenses have been
performed.
Finally, limitations of this study are the lack of patients with differ-
ent severity of KC. It might be interesting to investigate the influence
of KC severity to confirm our lack of correlation between severity,
dry eye signs and symptoms. Eye rubbing was reported by 13 kerato-
conus patients, 6 non-RPG lens wearers and 7 RGP wearers. The pa-
tients who related eye rubbing showed a higher concentration of din-
ucleotides and Mcmonnies score than non-rubbing eyes in both KC
subgroups. However, the sample size for this parameter is too small
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In conclusion, the parameters evaluated in this study indicate that
patients with KC have more severe signs and symptoms of dry eye
than subjects without KC, which could be exacerbated when the pa-
tient wears gas permeable contact lenses.
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